Early in vitro testing for adverse effects on embryos

A chip with four rows of the new embryotoxicity test. (Photograph: ETH Zurich / Julia Boos)
A chip with four rows of the new embryotoxicity test. (Photograph: ETH Zurich / Julia Boos)

ETH researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that new medications may have on embryos early on in the drug development process.

ETH-News

Helen Stauffer

News